Expertise in
3
conditions

Jurgen Verbist

Ziekenhuis Oost Limburg
Genk, VLG, BE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
3
conditions
Ziekenhuis Oost Limburg
Genk, VLG, BE 

Overview

Jurgen Verbist practices practicing medicine in Genk, Belgium.

Verbist is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Peripheral Artery Disease, Atherosclerosis, May Thurner Syndrome, Angioplasty, and Stent Placement.

They are actively involved in clinical research, co-authoring 37 peer reviewed articles and participating in 10 clinical trials.

Locations

Ziekenhuis Oost Limburg
Genk, VLG, Belgium
Other Locations
Bonheiden, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

An RCT Evaluating the Safety and Efficacy of the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy
An RCT Evaluating the Safety and Efficacy of the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy
Enrollment Status: Recruiting
Publish Date: October 16, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Belgian Physician-initiated Trial Investigating the LifeStream Peripheral Stent Graft System for the Treatment of Complex TASC C and D Iliac Lesions
Belgian Physician-initiated Trial Investigating the LifeStream Peripheral Stent Graft System for the Treatment of Complex TASC C and D Iliac Lesions
Enrollment Status: Completed
Publish Date: March 05, 2026
Intervention Type: Device
Study Phase: Not Applicable
Stellarex Vascular E-Registry
Stellarex Vascular E-Registry
Enrollment Status: Completed
Publish Date: August 14, 2025
Intervention Type: Device
Physician Initiated, Prospective, Non-randomized Belgian Multi-center Trial, Investigating the Safety and Efficacy of the Treatment With the LumINor DCB and The IvolutioN Stent of iVascular in TASC C and D Femoropopliteal Atherosclerotic Disease
Physician Initiated, Prospective, Non-randomized Belgian Multi-center Trial, Investigating the Safety and Efficacy of the Treatment With the LumINor DCB and The IvolutioN Stent of iVascular in TASC C and D Femoropopliteal Atherosclerotic Disease
Enrollment Status: Completed
Publish Date: March 06, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
Enrollment Status: Completed
Publish Date: February 24, 2025
Intervention Type: Device
Study Phase: Not Applicable
Belgian-Italian Prospective, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of BTK Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular of 150 Subjects With Critical Limb Ischemia
Belgian-Italian Prospective, Single Arm, Multicentre Study to Evaluate the Efficacy and Safety of BTK Treatment With the Luminor 14 Paclitaxel Coated Percutaneous Transluminal Angioplasty Balloon Catheter of iVascular of 150 Subjects With Critical Limb Ischemia
Enrollment Status: Completed
Publish Date: November 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
Belgo-France Physician-initiated Trial Investigating the BeGraft Peripheral Plus Stent Graft System for the Treatment of Iliac Lesions (TASC A, B, C and D)
Belgo-France Physician-initiated Trial Investigating the BeGraft Peripheral Plus Stent Graft System for the Treatment of Iliac Lesions (TASC A, B, C and D)
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects with Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
A Randomized Controlled Non-inferiority Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of Subjects with Stenotic, Restenotic or Occlusive Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Single-arm, Multi-center, Observational Study to Further Confirm Safety and Efficacy of the Dual-layer Micromesh Roadsaver Stent for the Treatment of Carotid Artery Stenosis in Patients Eligible for Elective Stenting Procedure
Prospective, Single-arm, Multi-center, Observational Study to Further Confirm Safety and Efficacy of the Dual-layer Micromesh Roadsaver Stent for the Treatment of Carotid Artery Stenosis in Patients Eligible for Elective Stenting Procedure
Enrollment Status: Completed
Publish Date: March 21, 2023
Intervention Type: Device
A Single-Arm, Multicenter Study for the Lower Extremities Using the Vanguard IEP Peripheral Balloon Angioplasty System With Integrated Embolic Protection
A Single-Arm, Multicenter Study for the Lower Extremities Using the Vanguard IEP Peripheral Balloon Angioplasty System With Integrated Embolic Protection
Enrollment Status: Completed
Publish Date: July 10, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

37 Total Publications

Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCT.
Head-to-head comparison of two paclitaxel-coated balloons for femoropopliteal lesions: 3-year results from the BIOPACT RCT.
Journal: The Journal of cardiovascular surgery
Published: December 23, 2025

Frequently Asked Questions about Jurgen Verbist

Is Jurgen Verbist a top-rated expert for Peripheral Artery Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Jurgen Verbist is classified as an Distinguished expert for Peripheral Artery Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jurgen Verbist participate in research or clinical trials?

Yes. Jurgen Verbist has published 37 articles and abstracts on conditions like Peripheral Artery Disease. You can view a list of Jurgen Verbist's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Verbist's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile